Literature DB >> 17616846

Introducing new screens: why are we all doing different things?

R J Pollitt1.   

Abstract

The disease panels covered by newborn blood spot screening vary greatly from country to country. There are different interpretations of the Wilson and Jungner principles and of underlying data in the scientific literature, and great disparities between the value judgements applied in screening and in routine clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17616846     DOI: 10.1007/s10545-007-0647-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

Review 1.  Principles and performance: assessing the evidence.

Authors:  R J Pollitt
Journal:  Acta Paediatr Suppl       Date:  1999-12

2.  Screening for lysosomal storage disorders--a clinical perspective.

Authors:  Janice M Fletcher
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  International perspectives on newborn screening.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Newborn screening technology: proceed with caution.

Authors:  Jeffrey R Botkin; Ellen Wright Clayton; Norman C Fost; Wylie Burke; Thomas H Murray; Mary Ann Baily; Benjamin Wilfond; Alfred Berg; Lainie Friedman Ross
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

5.  State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.

Authors:  Beth A Tarini; Dimitri A Christakis; H Gilbert Welch
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

6.  [The advisory report 'Neonatal screening' from the Health Council of The Netherlands].

Authors:  P A Bolhuis; G C M L Page-Christiaens
Journal:  Ned Tijdschr Geneeskd       Date:  2005-12-17

7.  A vision of the future of newborn screening.

Authors:  Duane Alexander; Peter C van Dyck
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

8.  Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program.

Authors:  Caren I Lanting; David A van Tijn; J Gerard Loeber; Thomas Vulsma; Jan J M de Vijlder; Paul H Verkerk
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

9.  Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific.

Authors:  R Fingerhut; W Röschinger; A C Muntau; T Dame; J Kreischer; R Arnecke; A Superti-Furga; H Troxler; B Liebl; B Olgemöller; A A Roscher
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

10.  Newborn screening: toward a uniform screening panel and system.

Authors: 
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

View more
  17 in total

1.  Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance.

Authors:  Peter Burgard; Kathrin Rupp; Martin Lindner; Gisela Haege; Tessel Rigter; Stephanie S Weinreich; J Gerard Loeber; Domenica Taruscio; Luciano Vittozzi; Martina C Cornel; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2012-04-28       Impact factor: 4.982

Review 2.  Genetic screening: A primer for primary care.

Authors:  Anne Andermann; Ingeborg Blancquaert
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

3.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

Review 4.  The consequences of extended newborn screening programmes: do we know who needs treatment?

Authors:  B Wilcken
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.982

Review 5.  Newborn blood spot screening: new opportunities, old problems.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2009-05-04       Impact factor: 4.982

Review 6.  Newborn screening: how are we travelling, and where should we be going?

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2011-04-16       Impact factor: 4.982

Review 7.  Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2010-03-03       Impact factor: 4.246

Review 8.  International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.

Authors:  Marleen E Jansen; Selina C Metternick-Jones; Karla J Lister
Journal:  Eur J Hum Genet       Date:  2016-11-16       Impact factor: 4.246

9.  Consent for newborn screening: parents' and health-care professionals' experiences of consent in practice.

Authors:  Holly Etchegary; Stuart G Nicholls; Laure Tessier; Charlene Simmonds; Beth K Potter; Jamie C Brehaut; Daryl Pullman; Robyn Hayeems; Sari Zelenietz; Monica Lamoureux; Jennifer Milburn; Lesley Turner; Pranesh Chakraborty; Brenda Wilson
Journal:  Eur J Hum Genet       Date:  2016-06-15       Impact factor: 4.246

10.  Incidental findings in genetics research using archived DNA.

Authors:  Ellen Wright Clayton
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.